Ariad Pharmaceuticals Inc fka ARIA

[glass_half_full]

Just because a trial is stat sig at an interim does not get it stopped

Why were the Phase 3 trials in everolimus and temsirolimus stopped then, at the interim?

I think there is a difference between
(1) statistically significant from the placebo arm
and
(2) unethical to continue the placebo arm.

Additionally, IIRC, the current trend is away from stopping trials early based on follow-on evidence that the arms in some stopped trials could have re-converged.

JMHO.